Surgical Hemostats Market Players:
- Ethicon, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Baxter International Inc.
- Medtronic plc
- B. Braun Melsungen AG
- Pfizer Inc.
- CryoLife, Inc.
- C.R. Bard, Inc.
- Integra LifeSciences Corporation
- Z-Medica, LLC
- Cardinal Health, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of surgical hemostats is assessed at USD 4.76 billion.
The global surgical hemostats market size surpassed USD 4.51 billion in 2025 and is projected to witness a CAGR of more than 6.2%, crossing USD 8.23 billion revenue by 2035.
North America surgical hemostats market is expected to capture 35% share by 2035, driven by rising healthcare spending and adoption of advanced surgical techniques including robotic-assisted surgeries.
Key players in the market include Ethicon, Inc., Baxter International Inc., Medtronic plc, B. Braun Melsungen AG, Pfizer Inc., CryoLife, Inc., C.R. Bard, Inc., Integra LifeSciences Corporation, Z-Medica, LLC, Cardinal Health, Inc.
